Kenneth Galbraith laid out the Vancouver-based biotech’s strategic priorities for the next two years after markets closed Wednesday. He said the company will focus on cost efficiency, which included the exit of half the company’s senior management team and a promise to reduce headcount by at least 25 per cent by the end of the year. (The Logic)
In-depth, agenda-setting reporting
Great journalism delivered straight to your inbox.
How machine learning is transforming biotech research
Crush of cargo containers sends West Coast ports to bottom of global rankings
China’s Tencent pulled out of financing ‘Top Gun: Maverick’ over pro-U.S. messaging
CPP Investments launches growth equity group
Best business newsletter in Canada
Get up to speed in minutes with insights and analysis on the most important stories of the day, every weekday.
See the bigger picture with reporters and industry experts in subscriber-exclusive events.
Membership in The Logic Council
Membership provides access to our popular Slack channel, participation in subscriber surveys and invitations to exclusive events with our journalists and special guests.